Can Buerger's Disease Lead to Cutaneous Vasculitis?
Yes, Buerger's disease (thromboangiitis obliterans) is itself a vasculitis that can manifest with cutaneous findings, though it is not typically classified as causing "cutaneous vasculitis" in the traditional sense—rather, it IS a vasculitis that affects the skin through ischemic manifestations.
Understanding Buerger's Disease as a Vasculitic Process
Buerger's disease is fundamentally a nonatherosclerotic inflammatory vasculitis that primarily targets small- and medium-sized distal arteries and veins 1, 2. The key distinction here is important: rather than "leading to" cutaneous vasculitis as a secondary phenomenon, Buerger's disease itself represents a vasculitic process with prominent cutaneous manifestations.
The Vasculitic Nature
Multiple authoritative guidelines consistently describe Buerger's disease as:
- A vasculitis that "behaves like a vasculitis" affecting arteries of all sizes (though predominantly smaller distal vessels) 2
- A nonatherosclerotic inflammatory vasculitis with segmental, thrombotic inflammation of vessels 1, 3
- An occlusive vasculitis causing ischemia in small and medium vessels 4
Cutaneous Manifestations
The cutaneous findings in Buerger's disease result from the underlying vasculitic process and include:
- Superficial thrombophlebitis (progressively worsening) 1
- Non-healing ulcerations (typically acrally localized) 3, 5
- Ischemic changes: rest pain, gangrene, and tissue necrosis 1, 5
- Migrating thrombophlebitis as a distinctive feature 6
Rare Acute Vasculitic Presentations
There is limited evidence suggesting that acute cutaneous vasculitis can occur as a distinct manifestation. One guideline notes that "rarely, there have been cases reported of acute cutaneous vasculitis in tattoo recipients occurring 10 to 14 days after placement" with symptoms including "chills, arthralgia, myalgia, and purpuric rash" 7. However, this appears to be discussing vasculitis from tattoo complications rather than Buerger's disease specifically.
Clinical Algorithm for Recognition
When evaluating a patient with suspected Buerger's disease and cutaneous findings:
Look for the classic triad:
Identify characteristic cutaneous signs:
Exclude other vasculitides and causes:
Critical Distinction from Other Vasculitides
Unlike systemic vasculitides that may secondarily affect the skin (such as Behçet's disease, which is noted as one of only two vasculitides that can involve both arteries AND veins 9), Buerger's disease is primarily a peripheral vascular vasculitis with cutaneous manifestations being direct consequences of vessel occlusion rather than a separate cutaneous vasculitis process.
Treatment Implications
The cornerstone of treatment remains absolute smoking cessation 2, 8, 4, 10. This is non-negotiable—continued tobacco use is associated with disease progression, amputation, and poor outcomes 2, 8. Additional therapies include:
- Prostacyclin analogues for critical ischemia 10
- Local wound care 10
- Consideration of revascularization in select cases 11
- Emerging therapies: progenitor cell therapy, immunoadsorption, bosentan, phosphodiesterase-V inhibitors 12
Common Pitfall
Do not confuse the ischemic cutaneous manifestations of Buerger's disease with primary cutaneous vasculitis (such as leukocytoclastic vasculitis). The skin findings in Buerger's disease result from arterial and venous occlusion due to the underlying vasculitic process, not from direct immune-mediated damage to dermal vessels as seen in true cutaneous vasculitis.